
Trioar
Innovative drug development accelerating research and reducing costs to create a better future for humanity.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
* | KRW2.5m | Series B | |
Total Funding | 000k |
Related Content
Triore is a pioneering drug development company focused on creating innovative pharmaceutical solutions to improve global health. Operating in the biotechnology and pharmaceutical sectors, Triore serves a diverse range of clients including healthcare providers, research institutions, and pharmaceutical companies. The company leverages its advanced research infrastructure and cutting-edge technology to expedite drug development processes while minimizing costs. Triore's business model revolves around research and development (R&D), where it invests in discovering and developing new drugs, which are then licensed or sold to larger pharmaceutical firms. Revenue is generated through licensing agreements, partnerships, and direct sales of developed drugs. The company is committed to its core values of insight, faith, and constant challenge, aiming to create a better future for mankind through its innovative solutions.
Keywords: drug development, biotechnology, pharmaceutical, research, innovation, healthcare, R&D, licensing, partnerships, global health.